"We Envision Growth Strategies Most Suited
to Your Business"
The poultry health & performance industry involves using multiple products to manage poultry sickness and help with increasing the poultry productivity. As the worldwide economy grows, it is expected that international trade opportunities will rise, as there will be growing demands for poultry products, which will subsequently have greater chances for sickness outbreaks such as HPAI. More recent developments within the industry indicate that there is a growing awareness of multiple poultry-related illnesses and, therefore, the need to prevent these illnesses including IBD, Marek’s disease, coccidiosis, Newcastle disease, and avian flu. In addition to this, top 10 poultry health & performance companies are actively developing innovative vaccines for the poultry segment, which is supported by various government initiatives to improve poultry health.
Some of the significant emerging trends seen within the global poultry health & performance industry include increasing vaccination trends for poultry (>10,000 hatcheries do so) at hatcheries. The vaccination of poultry at hatcheries involves vector vaccines and combination products. Therefore, this emerging trend reduces field labor, increases protection for birds, and provides significant protection for birds at an earlier age during their life cycle.
Fueled by these factors, as per Fortune Business Insights, the market for poultry health & performance reached USD 11.56 billion in 2025. It is anticipated to hit USD 20.85 billion in 2034, with a CAGR of 6.82% during the forecast period.
Boehringer Ingelheim International GmbH is a well-renowned, research-based pharmaceutical company focused on human, animal, and biopharmaceuticals. Headquartered in Germany and established in 1885, the company has more than 52,000 employees globally. The company is focused on developing new treatment options that address unmet medical needs within the fields of cardiology, respiratory, oncology, and immunology.
The original Vaxxitek HVT+IBD, launched by Boehringer Ingelheim Animal Health in 2006, was the first ever HVT-based vectored viral vaccine developed for poultry. The vector used in HVT is the herpesvirus of turkeys. The vectored vaccine is a bioengineering construct. The HVT vector carries the genes of the immunogenic protein of one or more viruses in this case IBD.
Headquartered in Germany, Merck & Co., Inc. is a biopharma company that discovers, develops, manufactures and markets biopharmaceutical products, such as medicines, vaccines, biologic therapies, and animal health products. Their product offerings include prescription medications sold through various therapeutic areas of oncology, vaccines, immunology, neuroscience, and ophthalmology.
Merck Animal Health announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. In March 2019, Merck Animal Health invested in Poultry Sense Ltd., to support their development. Poultry Sense provides enhanced technology for poultry farmers to monitor and analyze health performance of the flock. This innovative technology is an important tool used to assess an animal’s health and well-being. It also enhances productivity and efficacy measures on the farm and, ultimately, to better food safety and security.
Ceva, headquartered in Libourne, France, has established itself as a leading global company that provides products and services to support poultry health & performance by providing research, development and marketing of innovative vaccines, equipment, and services.
In November 2024, the company launched its latest innovation ‘Ceva Genesys’, which is a technology that is specifically designed for automatically and accurately separating broiler males and females at the time of hatch. This new technology enables poultry producers to improve their overall flock homogeneity, which is especially important considering the growing demand for poultry meat along with the increasing pressure to produce sustainable poultry meat.
Zoetis Inc. is the world’s leading independent animal health company, discovering, developing, and manufacturing vaccines, medicines, and diagnostics for pets and livestock. Formerly a Pfizer subsidiary, it operates in more than 70 countries, offering a "continuum of care" for animals. It is headquartered in New Jersey, U.S.
In April 2024, Zoetis Inc. and Phibro Animal Health Corporation announced an agreement to acquire Zoetis’ medicated feed additive (MFA) product portfolio, several water-soluble products, and related assets for USD 350 million
Elanco is one of the top 10 poultry health & performance which is headquartered in the U.S., and is devoted to improvement in both pet and farm animal care. Formerly part of Eli Lilly and Company, Elanco became an independent company in 2019 and is now laser-focused on refining the health of pets and providing safe, sustainable food sources from animals. Elanco offers veterinarians, pet owners, and producers a variety of products, including vaccines, parasiticides, and therapeutic options.
In June 2012, following the acquisition of Janssen Animal Health, Elanco launched a poultry tonic to help ease the burden on the poultry industry. As a result of this acquisition, Elanco has enhanced its existing poultry tonic offering by introducing an innovative formula containing two major ingredients designed to help support bird health during their most productive times.
Phibro Animal Health Corp. is a multinational company that produces a variety of products for the animal health and mineral nutrition industry. Phibro’s headquarter is located in the U.S. They provide more than 2,000 unique products including vaccines, anti-microbial, and specialty nutrition products to more than 95 countries. Their products are designed to improve the health, nutrition, and productivity of livestock and fish and ultimately enhance the health and welfare of all food-producing livestock and fish.
Novozymes A/S ranks as one of the largest industrial biotechnology companies in the world, focused on producing enzymes, micro-organisms, and biopharmaceutical ingredients. It is headquartered in Denmark.
In January 2024, Novozymes A/S merged with Chr. Hansen to form Novonesis. Novonesis is a global leader in bio-solutions for the poultry industry, focusing on enhancing health, performance, and sustainability through enzymes and probiotics. These solutions are intended to provide improved feed conversion ratios, provide support for gut health, and reduce environmental impact from poultry production.
Headquartered in the Netherlands, DSM-Firmenich operates as a science-based company that offers services and products in the field of nutrition, health, and beauty. The company is involved in primary activities such as innovation, manufacturing, and combination of nutrients, flavors, and fragrances.
In November 2025, Ingredients leader DSM-Firmenich launched a machine learning-based precision service called Verax service, for hens raised for egg production, which the company claims can help poultry producers improve overall animal health, productivity, and welfare. The Verax service can predict performance drops, stress events, and health challenges through advanced data analytics. The company calls this a “first of its kind” early warning system.
Cargill, Inc., headquartered in the U.S., offers comprehensive poultry health & performance solutions through its Animal Nutrition & Health division, focusing on precision nutrition, microbiome intelligence, and gut health additives to enhance performance and welfare. Key innovations include postbiotics (Dia-V™ MB), water-based health additives (AviCare™), and microbiome mapping (Galleon™) to optimize immunity and reduce antibiotic reliance.
Headquartered in Denmark, Danisco Animal Nutrition and Health is a member of the international flavors and fragrances association's health and biosciences group. It is a well-recognized world leader in developing nutrients for animals raised for meat such as chickens, pigs, cattle, as well as pets. Danisco works on developing feed enzymes, probiotics, and betaine with the goal of enhancing gastrointestinal (GI) function, improving application efficiency, and promoting sustainability.
The poultry industry will be defined by precision, sustainability, and the rise of AI-based monitoring systems, new and innovative nutrition programs, and improved genetics. Increasing, poultry health & performance will be addressed through forging insect-based proteins into feed, real-time monitoring of flock welfare using smart sensors, and alternatives to antibiotics such as probiotics and phytogenic to support gut health and enhance immunity. By combining real-time monitoring of flock health using AI and IoT-based sensors, and utilizing computer vision systems, poultry producers will be able to quickly identify potential diseases and environmental issues including litter and air quality, which are affecting the birds.
With the elimination of antibiotic growth promoters, the top 10 poultry health & performance companies are now focusing on improving gut health to ensure the proper absorption of nutrients and the development of strong immune systems in birds. The industry is also increasingly adopting a holistic “One Health" approach that includes demonstrating optimal animal welfare while also ensuring environmental sustainability and producing safe and healthy food for consumers.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com